Effectiveness of the Polish program for the treatment of severe allergic asthma with omalizumab: a single-center experience

被引：0
作者：
Izabela Kupryś-Lipińska
Paweł Majak
Joanna Molinska
Piotr Kuna
机构：
[1] Barlicki University Hospital,Department of Internal Medicine, Asthma and Allergy
[2] Medical University of Lodz,undefined
来源：
BMC Pulmonary Medicine | / 16卷
关键词：
Effectiveness; Omalizumab; Severe asthma; Severe asthma exacerbations;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] 'Real-life' effectiveness studies of omalizumab in adult patients with severe allergic asthma: systematic review
    Abraham, I.
    Alhossan, A.
    Lee, C. S.
    Kutbi, H.
    MacDonald, K.
    ALLERGY, 2016, 71 (05) : 593 - 610
  • [32] Effectiveness and pharmacoeconomic analysis of the treatment of severe asthma with omalizumab in clinical practice
    Martinez-Moragon, Eva
    Climent, Maria
    Chiner, Eusebi
    Fernandez-Aracil, Cleofe
    Sanchez-Toril, Fernando
    Lluch-Tortajadas, Inmaculada
    Latay, Frederik
    Catalan, Pablo
    Garcia-Sidro, Patricia
    Pellicer, Concha
    Jose Bueso, Maria
    Lloris, Amparo
    Romero, Laura
    Miralles, Cristina
    Ordonez, Paola
    Gimenez Soler, Jose Vicente
    Landete, Pedro
    Berraondo, Javier
    FARMACIA HOSPITALARIA, 2019, 43 (03) : 101 - 109
  • [33] Omalizumab therapy for children and adolescents with severe allergic asthma
    Romano, Ciro
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2015, 11 (12) : 1309 - 1319
  • [34] "Real-life" Effectiveness Studies of Omalizumab in Adult Patients with Severe Allergic Asthma: Meta-analysis
    Alhossan, Abdulaziz
    Lee, Christopher S.
    MacDonald, Karen
    Abraham, Ivo
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2017, 5 (05) : 1362 - +
  • [35] Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry
    Gibson, P. G.
    Reddel, H.
    McDonald, V. M.
    Marks, G.
    Jenkins, C.
    Gillman, A.
    Upham, J.
    Sutherland, M.
    Rimmer, J.
    Thien, F.
    Katsoulotos, G. P.
    Cook, M.
    Yang, I.
    Katelaris, C.
    Bowler, S.
    Langton, D.
    Robinson, P.
    Wright, C.
    Yozghatlian, V.
    Burgess, S.
    Sivakumaran, P.
    Jaffe, A.
    Bowden, J.
    Wark, P. A. B.
    Yan, K. Y.
    Kritikos, V.
    Peters, M.
    Hew, M.
    Aminazad, A.
    Bint, M.
    Guo, M.
    INTERNAL MEDICINE JOURNAL, 2016, 46 (09) : 1054 - 1062
  • [36] Omalizumab Effectiveness in Severe Allergic Asthma with Multiple Allergic Comorbidities: A Post-Hoc Analysis of the STELLAIR Study
    Just, Jocelyne
    Thonnelier, Celine
    Bourgoin-Heck, Melisande
    Mala, Laurence
    Molimard, Mathieu
    Humbert, Marc
    JOURNAL OF ASTHMA AND ALLERGY, 2021, 14 : 1129 - 1138
  • [37] Omalizumab: An Optimal Choice for Patients with Severe Allergic Asthma
    Kotoulas, Serafeim Chrysovalantis
    Tsiouprou, Ioanna
    Fouka, Eva
    Pataka, Athanasia
    Papakosta, Despoina
    Porpodis, Konstantinos
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (02):
  • [38] Effectiveness of omalizumab across different dosing regimens in patients with moderate-to-severe allergic asthma
    Chase, Nicole M.
    Littlejohn, Monica
    Holweg, Cecile T. J.
    Millette, Lauren A.
    Seetasith, Arpamas
    Steinke, John W.
    Trzaskoma, Benjamin L.
    Hanania, Nicola A.
    Casale, Thomas B.
    RESPIRATORY MEDICINE, 2024, 223
  • [39] Effectiveness of omalizumab therapy in patients with highly severe allergic asthma treated in Department of Pulmonology in Krakow
    Gawlewicz-Mroczka, Agnieszka
    Zastrzezynska, Weronika
    Przybyszowski, Marek
    Cmiel, Adam
    Sladek, Krzysztof
    ALERGOLOGIA POLSKA-POLISH JOURNAL OF ALLERGOLOGY, 2016, 3 (04) : 127 - 133
  • [40] Cost-effectiveness analysis of omalizumab in adults and adolescents with moderate-to-severe allergic asthma
    Oba, Y
    Salzman, GA
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 114 (02) : 265 - 269
12345